Omeros reported $35.05M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acelrx Pharmaceuticals ACRX:US $ 9.44M 1.26M
Adma Biologics ADMA:US $ 50.59M 11.01M
Aerie Pharmaceuticals AERI:US $ 63.48M 552K
Alnylam Pharmaceuticals ALNY:US $ 359.99M 93.1M
Biomarin Pharmaceutical BMRN:US $ 382.03M 133.66M
Cytokinetics CYTK:US $ 81.7M 4.39M
Dynavax Technologies DVAX:US $ 83.23M 31.12M
Gilead Sciences GILD:US $ 6393M 89M
Heron Therapeutics HRTX:US $ 86.38M 12.19M
Insmed INSM:US $ 142.94M 12.26M
Intercept Pharmaceuticals ICPT:US $ 98.85M 14.42M
Knight Therapeutics Inc GUD:CN C$ 63.85M 8.85M
Macrogenics MGNX:US $ 77.74M 5.36M
Mirati Therapeutics MRTX:US $ 184.93M 12.45M
Pacira Pharmaceuticals PCRX:US $ 140.6M 14.38M
Pfizer PFE:US $ 15788M 3271M
Regulus Therapeutics RGLS:US $ 6.57M 391K
Sangamo Biosciences SGMO:US $ 73.49M 5.61M
Sarepta Therapeutics SRPT:US $ 297.71M 9.56M
United Therapeutics UTHR:US $ 175.6M 69.8M
Vertex Pharmaceuticals VRTX:US $ 1056.6M 138.24M
Vital Therapies VTL:US $ 21.44M 286K
Xoma XOMA:US $ 5.17M 408K